John M. Sorensen - Concepedia

Author

John M. Sorensen

National Cancer Institute

Also Known As

J M Sorensen, J SORENSEN, J Sörensen, J. M. Sorensen, J. Mel Sorensen, J.M. Sorensen, John M. Sorensen, John Sorensen

Publications

2.3K

Citations

H-Index

Concepts

All Affiliations

National Cancer Institute National Institutes of Health Massachusetts Institute of Technology Debiopharm (Switzerland)University of Michigan

About

John M. Sorensen is an author at National Cancer Institute specializing in medicine, pharmacotherapy, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Language Studies	3	3	370
2	Engineering	2	2	101
3	Health Sciences	2	2	238
4	Arts	1	1	55
5	Business	1	1	14

John M. Sorensen

Publications

1.8K

Citations

H-Index

Page 1

	Year	Citations
Hyperexcitability in fibromyalgia. John M. Sorensen, Thomas Graven‐Nielsen, K. G. Henriksson, PubMed	1998	287
Inhibition of fluorouracil-induced stomatitis by oral cryotherapy. D J Mahood, Ann Marie Dose, Charles L. Loprinzi, Journal of Clinical Oncology Cryotherapy ProcedureAnti-inflammatoryMedicineOral CavityOral Cryotherapy	1991	259
Fundamental Frequency in Sentence Production Ellen M. Kaisse, William E. Cooper, John M. Sorensen Language Fundamental FrequencySyntactic ParsingSpeech ArticulationPsycholinguisticsSpeech Science	1982	228
Treatment of hairy cell leukemia with 2-chlorodeoxyadenosine via the Group C protocol mechanism of the National Cancer Institute: a report of 979 patients. Bruce D. Cheson, John M. Sorensen, D. Vena, Journal of Clinical Oncology	1998	156
Carboxypeptidase-G2, thymidine, and leucovorin rescue in cancer patients with methotrexate-induced renal dysfunction. Brigitte C. Widemann, Frank M. Balis, Robert F. Murphy, Journal of Clinical Oncology	1997	127
A pilot study of interferon alfa-2a in combination with fluorouracil plus high-dose leucovorin in metastatic gastrointestinal carcinoma. Jean L. Grem, Nanette McAtee, Robert F. Murphy, Journal of Clinical Oncology Chemoprevention StrategyGastrointestinal OncologyMedicinePharmacologyPathology	1991	113
Treatment of refractory chronic lymphocytic leukemia with fludarabine phosphate via the group C protocol mechanism of the National Cancer Institute: five-year follow-up report. John M. Sorensen, D. Vena, Alfred Fallavollita, Journal of Clinical Oncology	1997	100
Fundamental frequency contours at syntactic boundaries William E. Cooper, John M. Sorensen The Journal of the Acoustical Society of America EngineeringLanguage ExperienceMorphology (Linguistics)Phrase BoundariesPhonology	1977	87
Phase I and Pharmacologic Study of the Specific Matrix Metalloproteinase Inhibitor BAY 12-9566 on a Protracted Oral Daily Dosing Schedule in Patients With Solid Malignancies Eric K. Rowinsky, Rachel Humphrey, Lisa A. Hammond, Journal of Clinical Oncology	2000	85
Tumor lysis syndrome: an uncommon complication of fludarabine therapy of chronic lymphocytic leukemia. Bruce D. Cheson, James N. Frame, D. Vena, Journal of Clinical Oncology	1998	81

Page 1